Telix Pharmaceuticals Limited American Depositary Shares TLX
$11.83
-7.79%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $21.00
- Implied Upside
- +77.5%
- Price Target Range
- $20.00 – $22.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-15 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $20 |
| 2026-09-14 | WedbushDavid Nierengarten |
Reiterates | Outperform | $22 |
| 2026-09-02 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $20 |
| 2026-08-20 | WedbushDavid Nierengarten |
Reiterates | Outperform | $22 |
| 2026-07-07 | CitigroupLaura Sutcliffe |
Maintains | Buy | $23 → $22 |
| 2026-07-07 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $20 |
| 2026-07-06 | WedbushDavid Nierengarten |
Reiterates | Outperform | $22 |
| 2026-04-13 | WedbushDavid Nierengarten |
Reiterates | Outperform | $22 |
| 2026-04-13 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $20 |
| 2026-04-07 | WedbushDavid Nierengarten |
Reiterates | Outperform | $22 |
| 2026-04-07 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $20 |
| 2026-02-24 | CitigroupLaura Sutcliffe |
Maintains | Buy | $22 → $23 |
| 2026-01-21 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $20 |
| 2025-12-22 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $20 |
| 2025-09-23 | UBSDavid Dai |
Maintains | Buy | $23 → $20 |
| 2025-09-18 | CitigroupLaura Sutcliffe |
Initiates coverage on | Buy | $22 |
| 2025-09-10 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $23 → $20 |
| 2025-08-28 | JP Morgan |
Downgrades | Overweight → Neutral | — |
| 2025-08-28 | WedbushDavid Nierengarten |
Reiterates | Outperform | $22 |
| 2025-07-03 | HC Wainwright & Co.Robert Burns |
Initiates coverage on | Buy | $23 |
| 2025-06-12 | WedbushDavid Nierengarten |
Reiterates | Outperform | $22 |
| 2025-06-05 | WedbushDavid Nierengarten |
Initiates coverage on | Outperform | $22 |
| 2025-01-27 | UBSLaura Sutcliffe |
Maintains | Buy | $21 → $22 |
| 2024-11-15 | UBSLaura Sutcliffe |
Initiates coverage on | Buy | $21 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $11.83
- Market Cap
- $4.02 billion
- 52-Week Range
- $6.28 – $13.11
- Average Volume
- 238K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.